🇺🇸 FDA
Patent

US 7407962

Heteroaryl compounds useful as inhibitors or protein kinases

granted A61PA61P1/16A61P11/06

Quick answer

US patent 7407962 (Heteroaryl compounds useful as inhibitors or protein kinases) held by Vertex Pharmaceuticals Incorporated expires Mon Jul 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Aug 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61P, A61P1/16, A61P11/06, A61P17/14, A61P19/00